Eric J. Bow

13.4k citations
79 papers · 10.6k · 5 hit papers · h-index 34

Impact in

Papers in

    • Antifungal resistance and susceptibility 31
    • Infection Control in Healthcare 2
    • Neutropenia and Cancer Infections 27

Eric J. Bow

78 papers receiving 10.1k citations

Eric J. Bow's Hit Papers

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial 2015 · 786 citations
7860+9+18Years since publication50010001.5k2.0k2.5k

Peers

Eric J. Bow
Comparison fields: 5 of 86
  • Infectious Diseases 3.7k
  • Oncology 3.5k
  • Applied Microbiology and Biotechnology 135
  • Molecular Medicine 174
  • Hematology 388
Replace Alison G. Freifeld with:
Alison G. Freifeld United States
James I. Ito United States
Kenneth V. I. Rolston United States
Jo‐Anne H. Young United States
Małgorzata Mikulska Italy
Georg Maschmeyer Germany
James C. Wade United States
Markus Ruhnke Germany
Lowell S. Young United States
Carolina García‐Vidal Spain
Eric J. Bow relative to Alison G. Freifeld United States Alison G. Freifeld's profile →
Citations per field
00.5×1.5×
Alison G. Freifeld · 1×
Citations per year

Countries citing papers authored by Eric J. Bow

Since Specialization
Citations

This map shows the geographic impact of Eric J. Bow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Bow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Bow more than expected).

Fields of papers citing papers by Eric J. Bow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric J. Bow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Bow. The network helps show where Eric J. Bow may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric J. Bow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric J. Bow Line = papers co-authored together Eric J. Bow links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Hit paper breakdown →
20112671
2
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
Hit paper breakdown →
20021562
3
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Hit paper breakdown →
2015786
4 2011584
5
Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases
Hit paper breakdown →
1998531
6 2018442
7 2008403
8
Combination Antifungal Therapy for Invasive Aspergillosis
Hit paper breakdown →
2015395
9 2013340
10 2018256
11 1999221
12 2002210
13 1991185
14 1995157
15 1999111
16 2011106
17 200698
18 198889
19 199786
20 201084

About Eric J. Bow

Eric J. Bow is a scholar working on Infectious Diseases, Oncology, Hematology, Emergency Medicine and Microbiology, having authored 79 papers that have together received 10.6k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (31 papers), Neutropenia and Cancer Infections (27 papers), Acute Myeloid Leukemia Research (4 papers), Emergency and Acute Care Studies (2 papers), Infection Control in Healthcare (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Central Venous Catheters and Hemodialysis (1 paper) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Infectious Diseases (3.7k citations), Oncology (3.5k citations), Applied Microbiology and Biotechnology (135 citations), Molecular Medicine (174 citations) and Hematology (388 citations). Eric J. Bow has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Kenneth V. I. Rolston, John R. Wingard, Kent A. Sepkowitz, Alison G. Freifeld, James I. Ito, ISSAM I. RAAD, Jo‐Anne H. Young, Craig A. Mullen, Gerald P. Bodey and Philip A. Pizzo. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Oncology, Cancer, The American Journal of Medicine and American Journal of Infection Control.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact